Comparative In Vitro Activity of New Lipoglycopeptides and Vancomycin Against Ocular Staphylococci and Their Toxicity on the Human Corneal Epithelium

The purpose of this study was to assess the potential of new lipoglycopeptides as novel topical therapies for improved treatment of recalcitrant ocular infections. We evaluated the in vitro antimicrobial activity of oritavancin, dalbavancin, and telavancin compared with vancomycin (VAN) against a la...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Camille, Islam, Mohammad Mirazul, Paschalis, Eleftherios, Bispo, Paulo J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2023
Materias:
Basic Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060036/
https://www.ncbi.nlm.nih.gov/pubmed/36455096
http://dx.doi.org/10.1097/ICO.0000000000003197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060036/
https://www.ncbi.nlm.nih.gov/pubmed/36455096
http://dx.doi.org/10.1097/ICO.0000000000003197

Ejemplares similares